DecisionBase 2009 Now Available from Decision Resources
Assesses Opportunity and Unmet Need in Thirty-Five Indications
Expanded Primary Research Includes European Physicians
“In response to these changing times, we have revamped our data and analysis tool DecisionBase to better address the needs of the drug industry,” stated
The new tool DecisionBase 2009 provides detailed market share, patient share and price-per-day projections for key current and emerging drugs in 35 indications across the G7 pharmaceutical markets (U.S.,
“In the commercial environment we examine pricing, reimbursement, regulatory issues and drug labeling,” added Dr. Drayton. “In the clinical environment, we evaluate clinical differentiators of key current and emerging therapies, factors that influence prescribing decisions and drug choice, patient population, country-specific medical practice and current therapies’ impact on quality of life measures.”
Indications covered in DecisionBase 2009 include:
Cardiovascular
- Acute Heart Failure
- Atrial Fibrillation
- Coronary Heart Disease (Stable Angina)
- NSTEMI (Non-ST-Elevated Myocardial
- Infarction)
- STEMI (ST-Elevated Myocardial
- Infarction)
- Venous Thromboembolism
CNS
- Alzheimer’s Disease (Mild-to-Moderate)
- Attention-Deficit/Hyperactivity Disorder
- Bipolar Depression
- Cognitive Impairment Associated with
- Schizophrenia
- Epilepsy
- Multiple Sclerosis (Relapsing-Remitting)
- Parkinson’s Disease
High Profile Diseases
- Erectile Dysfunction
Infectious Diseases
- Hepatitis C
- HIV
- Hospital-Acquired Pneumonia
Immune & Inflammatory Diseases
- Asthma
- Atopic Dermatitis
- Chronic Obstructive Pulmonary Disease
- Crohn’s Disease
- Psoriasis
- Rheumatoid Arthritis
- Ulcerative Colitis
Metabolic
- Type 1 Diabetes
- Type 2 Diabetes
Oncology
- Breast Cancer (HER2-Positive)
- Breast Cancer (Metastatic Triple Negative)
- Glioma (High Grade)
- Malignant Melanoma (Stage IV)
- Chronic Lymphocytic Leukemia (Relapsed/Refractory)
- Prostate Cancer (Metastatic, Hormone Refractory)
- Prostate Cancer (Stage III)
- Renal Cell Carcinoma (Metastatic)
Pain
- Chronic Low Back Pain
About Decision Resources
Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
Natalia Morales Elizabeth Marshall
Decision Resources Decision Resources, Inc.
781-296-2691 781-296-2563
nmorales@dresources.com emarshall@dresources.com
SOURCE Decision Resources
